8-K
Current Report
Xilio Therapeutics, Inc. Filed Acc 0001558370-22-014430
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading xlo-20220915x8k.htm…